These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34657098)

  • 41. CCL22-specific Antibodies Reveal That Engagement of Two Distinct Binding Domains on CCL22 Is Required for CCR4-mediated Function.
    Santulli-Marotto S; Wheeler J; Lacy ER; Boakye K; Luongo J; Wu SJ; Ryan M
    Monoclon Antib Immunodiagn Immunother; 2015 Dec; 34(6):373-80. PubMed ID: 26683175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CCL17 and CCL22 chemokines within tumor microenvironment are related to infiltration of regulatory T cells in esophageal squamous cell carcinoma.
    Maruyama T; Kono K; Izawa S; Mizukami Y; Kawaguchi Y; Mimura K; Watanabe M; Fujii H
    Dis Esophagus; 2010 Jul; 23(5):422-9. PubMed ID: 20002703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blockage of sphingosine-1-phosphate receptor 2 attenuates 2,4-dinitrochlorobenzene-induced atopic dermatitis in mice.
    Park SJ; Im DS
    Acta Pharmacol Sin; 2020 Nov; 41(11):1487-1496. PubMed ID: 32457418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6.
    Williams TC; Jackson DJ; Maltby S; Walton RP; Ching YM; Glanville N; Singanayagam A; Brewins JJ; Clarke D; Hirsman AG; Loo SL; Wei L; Beale JE; Casolari P; Caramori G; Papi A; Belvisi M; Wark PAB; Johnston SL; Edwards MR; Bartlett NW
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):344-356. PubMed ID: 33264064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Changes of TRGV genes and prognosis-related chemokine/receptor gene expressions in T cell lymphoma].
    Luo Q; Jin Z; Chen S; Yang L; Li B; Li W; Li Y; Wu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Mar; 33(3):362-366. PubMed ID: 28274317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
    Li JY; Ou ZL; Yu SJ; Gu XL; Yang C; Chen AX; Di GH; Shen ZZ; Shao ZM
    Breast Cancer Res Treat; 2012 Feb; 131(3):837-48. PubMed ID: 21479551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.
    Olkhanud PB; Baatar D; Bodogai M; Hakim F; Gress R; Anderson RL; Deng J; Xu M; Briest S; Biragyn A
    Cancer Res; 2009 Jul; 69(14):5996-6004. PubMed ID: 19567680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokines.
    Kondo T; Takiguchi M
    Int Immunol; 2009 May; 21(5):523-32. PubMed ID: 19261691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential roles of the CCL17-CCR4 axis in immunopathogenesis of oral lichen planus.
    Shan J; Shen C; Fang J; Li S; Fan Y
    J Oral Pathol Med; 2020 Apr; 49(4):328-334. PubMed ID: 31322295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A strategy to discover decoy chemokine ligands with an anti-inflammatory activity.
    Abboud D; Daubeuf F; Do QT; Utard V; Villa P; Haiech J; Bonnet D; Hibert M; Bernard P; Galzi JL; Frossard N
    Sci Rep; 2015 Oct; 5():14746. PubMed ID: 26442456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunosuppressive effects of CCL17 on pulmonary antifungal responses during pulmonary invasive aspergillosis.
    Carpenter KJ; Hogaboam CM
    Infect Immun; 2005 Nov; 73(11):7198-207. PubMed ID: 16239514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EBV+ tumors exploit tumor cell-intrinsic and -extrinsic mechanisms to produce regulatory T cell-recruiting chemokines CCL17 and CCL22.
    Jorapur A; Marshall LA; Jacobson S; Xu M; Marubayashi S; Zibinsky M; Hu DX; Robles O; Jackson JJ; Baloche V; Busson P; Wustrow D; Brockstedt DG; Talay O; Kassner PD; Cutler G
    PLoS Pathog; 2022 Jan; 18(1):e1010200. PubMed ID: 35025968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allopurinol suppresses expression of the regulatory T-cell migration factors TARC/CCL17 and MDC/CCL22 in HaCaT keratinocytes via restriction of nuclear factor-κB activation.
    Osabe M; Tajika T; Tohkin M
    J Appl Toxicol; 2018 Feb; 38(2):274-283. PubMed ID: 28949055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Affinity-coupled CCL22 promotes positive selection in germinal centres.
    Liu B; Lin Y; Yan J; Yao J; Liu D; Ma W; Wang J; Liu W; Wang C; Zhang L; Qi H
    Nature; 2021 Apr; 592(7852):133-137. PubMed ID: 33597749
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CCL17 exerts a neuroimmune modulatory function and is expressed in hippocampal neurons.
    Fülle L; Offermann N; Hansen JN; Breithausen B; Erazo AB; Schanz O; Radau L; Gondorf F; Knöpper K; Alferink J; Abdullah Z; Neumann H; Weighardt H; Henneberger C; Halle A; Förster I
    Glia; 2018 Oct; 66(10):2246-2261. PubMed ID: 30277599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduced locomotor activity and exploratory behavior in CC chemokine receptor 4 deficient mice.
    Ambrée O; Klassen I; Förster I; Arolt V; Scheu S; Alferink J
    Behav Brain Res; 2016 Nov; 314():87-95. PubMed ID: 27469058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Titanium induced production of chemokines CCL17/TARC and CCL22/MDC in human osteoclasts and osteoblasts.
    Cadosch D; Gautschi OP; Chan E; Simmen HP; Filgueira L
    J Biomed Mater Res A; 2010 Feb; 92(2):475-83. PubMed ID: 19205012
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4).
    Wang Y; Zhang Y; Yang X; Han W; Liu Y; Xu Q; Zhao R; Di C; Song Q; Ma D
    Life Sci; 2006 Jan; 78(6):614-21. PubMed ID: 16137713
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CCR4 is a determinant of melanoma brain metastasis.
    Klein A; Sagi-Assif O; Meshel T; Telerman A; Izraely S; Ben-Menachem S; Bayry J; Marzese DM; Ohe S; Hoon DSB; Erez N; Witz IP
    Oncotarget; 2017 May; 8(19):31079-31091. PubMed ID: 28415693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
    Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
    J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.